Below is a detailed analysis of the quarterly data for Balmer Lawrie Investment Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
For Sales, as of Mar 2025, the value is 611.00 Cr.. The value appears to be declining and may need further review. It has decreased from 633.00 Cr. (Dec 2024) to 611.00 Cr., marking a decrease of 22.00 Cr..
For Expenses, as of Mar 2025, the value is 514.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 547.00 Cr. (Dec 2024) to 514.00 Cr., marking a decrease of 33.00 Cr..
For Operating Profit, as of Mar 2025, the value is 97.00 Cr.. The value appears strong and on an upward trend. It has increased from 86.00 Cr. (Dec 2024) to 97.00 Cr., marking an increase of 11.00 Cr..
For OPM %, as of Mar 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Dec 2024) to 16.00%, marking an increase of 2.00%.
For Other Income, as of Mar 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Dec 2024) to 33.00 Cr., marking an increase of 11.00 Cr..
For Interest, as of Mar 2025, the value is 6.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.00 Cr. (Dec 2024) to 6.00 Cr., marking a decrease of 3.00 Cr..
For Depreciation, as of Mar 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.00 Cr. (Dec 2024) to 16.00 Cr., marking an increase of 1.00 Cr..
For Profit before tax, as of Mar 2025, the value is 107.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Dec 2024) to 107.00 Cr., marking an increase of 23.00 Cr..
For Tax %, as of Mar 2025, the value is 30.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Dec 2024) to 30.00%, marking an increase of 6.00%.
For Net Profit, as of Mar 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Dec 2024) to 75.00 Cr., marking an increase of 11.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 2.17. The value appears strong and on an upward trend. It has increased from 1.88 (Dec 2024) to 2.17, marking an increase of 0.29.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 2:40 pm
Metric
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,817
1,573
1,563
2,074
2,335
2,373
2,526
Expenses
1,547
1,347
1,413
1,883
2,110
2,024
2,204
Operating Profit
270
226
150
191
225
349
322
OPM %
15%
14%
10%
9%
10%
15%
13%
Other Income
58
59
79
65
81
73
115
Interest
7
15
12
14
18
22
27
Depreciation
30
52
55
57
57
59
60
Profit before tax
290
218
162
186
232
341
350
Tax %
30%
26%
26%
26%
26%
23%
24%
Net Profit
202
161
121
137
172
264
267
EPS in Rs
5.79
4.76
3.59
3.97
5.00
7.57
7.73
Dividend Payout %
59%
79%
106%
75%
66%
50%
56%
×
Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
2019-2020
2020-2021
2021-2022
2022-2023
2023-2024
2024-2025
YoY Net Profit Growth (%)
-20.30%
-24.84%
13.22%
25.55%
53.49%
1.14%
Change in YoY Net Profit Growth (%)
0.00%
-4.55%
38.07%
12.32%
27.94%
-52.35%
Balmer Lawrie Investment Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
Compounded Sales Growth
10 Years:
%
5 Years:
10%
3 Years:
7%
TTM:
6%
Compounded Profit Growth
10 Years:
%
5 Years:
10%
3 Years:
26%
TTM:
2%
Stock Price CAGR
10 Years:
12%
5 Years:
15%
3 Years:
30%
1 Year:
-6%
Return on Equity
10 Years:
%
5 Years:
11%
3 Years:
12%
Last Year:
13%
Last Updated: Unknown
No data available for the Balance Sheet data table.
Reserves and Borrowings Chart
Cash Flow
Month
Month
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Cash from Operating Activity +
177
187
247
23
206
269
164
Cash from Investing Activity +
-137
-60
-80
137
-48
-105
9
Cash from Financing Activity +
-61
-159
-153
-148
-145
-172
-183
Net Cash Flow
-21
-32
14
12
13
-9
-10
Free Cash Flow Chart
Financial Efficiency Indicators
Month
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Debtor Days
56
63
67
55
56
66
Inventory Days
47
58
58
51
47
47
Days Payable
0
88
99
68
69
75
Cash Conversion Cycle
102
33
27
38
35
37
Working Capital Days
42
51
32
51
41
42
ROCE %
13%
9%
11%
13%
18%
Financial Efficiency Indicators Chart
Share Holding Pattern
Month
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Promoters
59.67%
59.67%
59.67%
59.67%
59.67%
59.67%
59.67%
59.67%
59.67%
59.67%
59.67%
59.67%
FIIs
3.35%
1.25%
0.67%
0.66%
0.32%
0.38%
0.68%
0.82%
1.08%
1.33%
1.31%
1.14%
DIIs
0.15%
0.14%
0.14%
0.14%
0.14%
0.14%
0.14%
0.14%
0.14%
0.14%
0.02%
0.02%
Public
36.83%
38.93%
39.51%
39.51%
39.87%
39.81%
39.51%
39.37%
39.11%
38.85%
39.00%
39.16%
No. of Shareholders
20,106
21,537
23,572
23,217
23,265
23,359
26,514
23,794
22,802
24,873
41,756
48,459
Shareholding Pattern Chart
No. of Shareholders
This stock is not held by any mutual fund.
ROCE Trend
EPS Trend
Key Financial Ratios
Month
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
FaceValue
1.00
10.00
10.00
10.00
10.00
Basic EPS (Rs.)
0.77
75.68
49.98
39.88
35.92
Diluted EPS (Rs.)
0.77
75.68
49.98
39.88
35.92
Cash EPS (Rs.)
11.82
119.31
75.86
66.88
64.41
Book Value[Excl.RevalReserv]/Share (Rs.)
61.98
549.97
500.91
788.73
777.64
Book Value[Incl.RevalReserv]/Share (Rs.)
61.98
549.97
500.91
788.73
777.64
Revenue From Operations / Share (Rs.)
113.81
1057.87
1048.95
928.38
692.07
PBDIT / Share (Rs.)
16.78
164.10
110.61
94.86
88.56
PBIT / Share (Rs.)
14.06
137.44
85.02
69.73
63.78
PBT / Share (Rs.)
12.87
127.51
76.94
63.60
58.41
Net Profit / Share (Rs.)
9.10
92.65
50.28
41.74
39.62
NP After MI And SOA / Share (Rs.)
7.73
75.68
49.98
39.88
35.92
PBDIT Margin (%)
14.74
15.51
10.54
10.21
12.79
PBIT Margin (%)
12.35
12.99
8.10
7.51
9.21
PBT Margin (%)
11.30
12.05
7.33
6.85
8.43
Net Profit Margin (%)
7.99
8.75
4.79
4.49
5.72
NP After MI And SOA Margin (%)
6.79
7.15
4.76
4.29
5.18
Return on Networth / Equity (%)
12.47
13.76
9.97
7.92
7.26
Return on Capital Employeed (%)
12.47
13.21
8.76
7.56
7.09
Return On Assets (%)
5.36
5.55
3.96
3.43
3.15
Long Term Debt / Equity (X)
0.05
0.05
0.07
0.07
0.08
Total Debt / Equity (X)
0.05
0.06
0.08
0.08
0.08
Asset Turnover Ratio (%)
0.81
0.80
0.86
0.05
0.06
Current Ratio (X)
2.49
2.29
2.29
2.54
2.51
Quick Ratio (X)
2.22
2.02
1.98
2.16
2.20
Inventory Turnover Ratio (X)
8.30
7.48
7.88
0.00
0.00
Dividend Payout Ratio (NP) (%)
0.00
43.60
60.02
95.29
104.40
Dividend Payout Ratio (CP) (%)
0.00
32.24
39.70
58.45
61.77
Earning Retention Ratio (%)
0.00
56.40
39.98
4.71
-4.40
Cash Earning Retention Ratio (%)
0.00
67.76
60.30
41.55
38.23
Interest Coverage Ratio (X)
14.04
16.52
13.69
15.49
16.50
Interest Coverage Ratio (Post Tax) (X)
8.62
10.33
7.22
7.82
8.38
Enterprise Value (Cr.)
1724.29
1534.20
1027.01
1008.40
1085.04
EV / Net Operating Revenue (X)
0.68
0.65
0.44
0.48
0.70
EV / EBITDA (X)
4.63
4.21
4.18
4.79
5.52
MarketCap / Net Operating Revenue (X)
0.59
0.57
0.33
0.39
0.67
Retention Ratios (%)
0.00
56.39
39.97
4.70
-4.40
Price / BV (X)
1.09
1.11
0.70
0.73
0.94
Price / Net Operating Revenue (X)
0.59
0.57
0.33
0.39
0.67
EarningsYield
0.11
0.12
0.14
0.10
0.07
After reviewing the key financial ratios for Balmer Lawrie Investment Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 1.00, marking a decrease of 9.00.
For Basic EPS (Rs.), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 5. It has decreased from 75.68 (Mar 24) to 0.77, marking a decrease of 74.91.
For Diluted EPS (Rs.), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 5. It has decreased from 75.68 (Mar 24) to 0.77, marking a decrease of 74.91.
For Cash EPS (Rs.), as of Mar 25, the value is 11.82. This value is within the healthy range. It has decreased from 119.31 (Mar 24) to 11.82, marking a decrease of 107.49.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.98. It has decreased from 549.97 (Mar 24) to 61.98, marking a decrease of 487.99.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.98. It has decreased from 549.97 (Mar 24) to 61.98, marking a decrease of 487.99.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 113.81. It has decreased from 1,057.87 (Mar 24) to 113.81, marking a decrease of 944.06.
For PBDIT / Share (Rs.), as of Mar 25, the value is 16.78. This value is within the healthy range. It has decreased from 164.10 (Mar 24) to 16.78, marking a decrease of 147.32.
For PBIT / Share (Rs.), as of Mar 25, the value is 14.06. This value is within the healthy range. It has decreased from 137.44 (Mar 24) to 14.06, marking a decrease of 123.38.
For PBT / Share (Rs.), as of Mar 25, the value is 12.87. This value is within the healthy range. It has decreased from 127.51 (Mar 24) to 12.87, marking a decrease of 114.64.
For Net Profit / Share (Rs.), as of Mar 25, the value is 9.10. This value is within the healthy range. It has decreased from 92.65 (Mar 24) to 9.10, marking a decrease of 83.55.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 75.68 (Mar 24) to 7.73, marking a decrease of 67.95.
For PBDIT Margin (%), as of Mar 25, the value is 14.74. This value is within the healthy range. It has decreased from 15.51 (Mar 24) to 14.74, marking a decrease of 0.77.
For PBIT Margin (%), as of Mar 25, the value is 12.35. This value is within the healthy range. It has decreased from 12.99 (Mar 24) to 12.35, marking a decrease of 0.64.
For PBT Margin (%), as of Mar 25, the value is 11.30. This value is within the healthy range. It has decreased from 12.05 (Mar 24) to 11.30, marking a decrease of 0.75.
For Net Profit Margin (%), as of Mar 25, the value is 7.99. This value is within the healthy range. It has decreased from 8.75 (Mar 24) to 7.99, marking a decrease of 0.76.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.79. This value is below the healthy minimum of 8. It has decreased from 7.15 (Mar 24) to 6.79, marking a decrease of 0.36.
For Return on Networth / Equity (%), as of Mar 25, the value is 12.47. This value is below the healthy minimum of 15. It has decreased from 13.76 (Mar 24) to 12.47, marking a decrease of 1.29.
For Return on Capital Employeed (%), as of Mar 25, the value is 12.47. This value is within the healthy range. It has decreased from 13.21 (Mar 24) to 12.47, marking a decrease of 0.74.
For Return On Assets (%), as of Mar 25, the value is 5.36. This value is within the healthy range. It has decreased from 5.55 (Mar 24) to 5.36, marking a decrease of 0.19.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.05.
For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has increased from 0.80 (Mar 24) to 0.81, marking an increase of 0.01.
For Current Ratio (X), as of Mar 25, the value is 2.49. This value is within the healthy range. It has increased from 2.29 (Mar 24) to 2.49, marking an increase of 0.20.
For Quick Ratio (X), as of Mar 25, the value is 2.22. This value exceeds the healthy maximum of 2. It has increased from 2.02 (Mar 24) to 2.22, marking an increase of 0.20.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.30. This value exceeds the healthy maximum of 8. It has increased from 7.48 (Mar 24) to 8.30, marking an increase of 0.82.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 43.60 (Mar 24) to 0.00, marking a decrease of 43.60.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 32.24 (Mar 24) to 0.00, marking a decrease of 32.24.
For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 56.40 (Mar 24) to 0.00, marking a decrease of 56.40.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 67.76 (Mar 24) to 0.00, marking a decrease of 67.76.
For Interest Coverage Ratio (X), as of Mar 25, the value is 14.04. This value is within the healthy range. It has decreased from 16.52 (Mar 24) to 14.04, marking a decrease of 2.48.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.62. This value is within the healthy range. It has decreased from 10.33 (Mar 24) to 8.62, marking a decrease of 1.71.
For Enterprise Value (Cr.), as of Mar 25, the value is 1,724.29. It has increased from 1,534.20 (Mar 24) to 1,724.29, marking an increase of 190.09.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.68, marking an increase of 0.03.
For EV / EBITDA (X), as of Mar 25, the value is 4.63. This value is below the healthy minimum of 5. It has increased from 4.21 (Mar 24) to 4.63, marking an increase of 0.42.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.59, marking an increase of 0.02.
For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 56.39 (Mar 24) to 0.00, marking a decrease of 56.39.
For Price / BV (X), as of Mar 25, the value is 1.09. This value is within the healthy range. It has decreased from 1.11 (Mar 24) to 1.09, marking a decrease of 0.02.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.59, marking an increase of 0.02.
For EarningsYield, as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 24) to 0.11, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of Balmer Lawrie Investment Ltd as of July 1, 2025 is: 72.63
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of July 1, 2025, Balmer Lawrie Investment Ltd is Overvalued by 10.99% compared to the current share price 81.60
Intrinsic Value of Balmer Lawrie Investment Ltd as of July 1, 2025 is: 84.67
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of July 1, 2025, Balmer Lawrie Investment Ltd is Undervalued by 3.76% compared to the current share price 81.60
Last 5 Year EPS CAGR: 16.58%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balmer Lawrie Investment Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 12.47% (Industry Average ROE: 8.59%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 10.6 (Industry average Stock P/E: 88.12)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0.05
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
Balmer Lawrie Investments Ltd. is a Public Limited Listed company incorporated on 20/09/2001 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L65999WB2001GOI093759 and registration number is 093759. Currently company belongs to the Industry of Non-Banking Financial Company (NBFC). Company's Total Operating Revenue is Rs. 101.11 Cr. and Equity Capital is Rs. 22.20 Cr. for the Year ended 31/03/2025.
INDUSTRY
ADDRESS
CONTACT
Non-Banking Financial Company (NBFC)
21, Netaji Subhas Road, Kolkata West Bengal 700001
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Balmer Lawrie Investment Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
